 08 AM / in 5 minutes BRIEF-Biocryst Advancing Potential Treatment For Rare And Severely Debilitating Fibrodysplasia Ossificans Progressiva Reuters Staff 
Jan 5 (Reuters) - Biocryst Pharmaceuticals Inc: 
* BIOCRYST ADVANCING POTENTIAL TREATMENT FOR RARE AND SEVERELY DEBILITATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA 
* BIOCRYST PHARMACEUTICALS - IND FOR NONCLINICAL DEVELOPMENT OF BCX9250,BCX9499 INITIATED WITH GOAL OF PROGRESSING TO PHASE 1 CLINICAL TRIALS IN H1 2019 Source text for Eikon: Further company coverage: